New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products-Reference-Cited by-同舟云学术

New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products

Published:2012-11-04 Issue:1 Volume:31 Page:93-100
ISSN:1860-8965
Container-title:Forensic Toxicology
language:en
Short-container-title:Forensic Toxicol

Author:

Uchiyama Nahoko,Matsuda Satoru,Wakana Daigo,Kikura-Hanajiri Ruri,Goda Yukihiro

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Toxicology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11419-012-0171-4.pdf

Reference19 articles.

1. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2012) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan. Forensic Toxicol (in press)

2. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Ogata J, Goda Y (2012) Prevalence of new designer drugs and their legal status in Japan (in Japanese with English abstract). Yakugaku Zasshi (in press)

3. EMCDDA (2012) “EMCDDA–Europol 2011 annual report on the implementation of council decision 2005/387/JHA”. EMCDDA/Europol, Lisbon. http://www.emcdda.europa.eu/publications/implementation-reports/2011 . Accessed April 2012

4. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y (2009) Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 57:439–441

5. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N (2009) ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic characteristic profiling of 1-amino-3,3-dimethyl-1-oxobutan-2-yl-derived indole and indazole synthetic cannabinoids in vitro;Journal of Pharmaceutical and Biomedical Analysis;2024-11

2. Rapid Nuclease-Assisted Selection of High-Affinity Small-Molecule Aptamers;Journal of the American Chemical Society;2024-07-23

3. Into the synthetic cannabinoid 5-Fluoro-MDMB-PICA in “American grass” illicit drug: Extraction, isolation, structure elucidation, and GC/MS determination;Talanta Open;2023-12

4. The Effect of the Synthetic Cannabinoid AB-CHMINACA on the Roles of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Brain Angiogenesis;Applied In Vitro Toxicology;2023-09-01

5. EMCDDA framework and practical guidance for naming synthetic cannabinoids;Drug Testing and Analysis;2022-11-28